Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
The mainstay of toxoplasmosis treatment targets the folate biosynthetic pathways and has not changed for the last 50 years. The activity of these chemotherapeutic agents is restricted to one lifecycle stage of Toxoplasma gondii, they have significant toxicity, and the impending threat of emerging re...
Saved in:
Main Authors: | Rosa M Andrade (Author), Juan D Chaparro (Author), Edmund Capparelli (Author), Sharon L Reed (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental Porcine Toxoplasma gondii Infection as a Representative Model for Human Toxoplasmosis
by: Julia Nau, et al.
Published: (2017) -
Presence and duration of anti‐Toxoplasma gondii immunoglobulin M in infants with congenital toxoplasmosis
by: Eleonor G. Lago, et al.
Published: (2014) -
Presence and duration of anti-Toxoplasma gondii immunoglobulin M in infants with congenital toxoplasmosis
by: Eleonor G. Lago, et al.
Published: (2014) -
Presence and duration of anti-Toxoplasma gondii immunoglobulin M in infants with congenital toxoplasmosis
by: Eleonor G. Lago, et al.
Published: (2014) -
Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor
by: Won Hyung Choi, et al.
Published: (2018)